Payment overview · 2025
General Payments
$129.04
6 reported records · 3 companies
Healthcare provider profile · identity verified
Heidi E Helgeson, MD
Allopathic & Osteopathic Physicians|Family Medicine · DEL NORTE, CO · NPI 1740474931
Verified facts
What the public records show
CMS Open Payments records show Heidi E Helgeson, MD received $129.04 in general payments during 2025 across 6 reported records.
ABBVIE INC. accounted for 66.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARMOUR THYROID as an associated drug or biological on 50 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Armour Thyroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Synthroid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $86.37 | 66.9% | 4 | 2025 |
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $28.75 | 22.3% | 1 | 2025 |
| Xeris Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $13.92 | 10.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $129.04 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $86.37 | 4 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $64.99 | 3 | 2025 |
Source payment records
|
|||||
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $28.75 | 1 | 2025 |
Source payment records
|
|||||
| GVOKE HYPOPEN Normalized: gvoke hypopen |
Drug | Xeris Pharmaceuticals, Inc. | $13.92 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | ARMOUR THYROID open payments reported associated product |
CMS Open Payments — General Payments 50 supporting records · 11 recipient NPIs · example record 1201517088 |
Armour Thyroid · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 488 | 119 |
| Levothyroxine Sodium | Levothyroxine Sodium | 477 | 97 |
| Lisinopril | Lisinopril | 418 | 94 |
| Gabapentin | Gabapentin | 293 | 64 |
| Amlodipine Besylate | Amlodipine Besylate | 288 | 73 |
| Metformin Hcl | Metformin Hcl | 267 | 63 |
| Furosemide | Furosemide | 259 | 46 |
| Losartan Potassium | Losartan Potassium | 254 | 60 |
| Pantoprazole Sodium | Pantoprazole Sodium | 163 | 35 |
| Tamsulosin Hcl | Tamsulosin Hcl | 162 | 42 |
| Omeprazole | Omeprazole | 157 | 55 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 153 | 21 |
| Eliquis | Apixaban | 149 | 22 |
| Potassium Chloride | Potassium Chloride | 147 | 39 |
| Tramadol Hcl | Tramadol Hcl | 145 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 144 | 35 |
| Montelukast Sodium | Montelukast Sodium | 132 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 131 | 24 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 131 | 30 |
| Xarelto | Rivaroxaban | 125 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 122 | 25 |
| Oxycodone Hcl | Oxycodone Hcl | 122 | 21 |
| Sertraline Hcl | Sertraline Hcl | 121 | 29 |
| Simvastatin | Simvastatin | 121 | 28 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 112 | 17 |
| Trazodone Hcl | Trazodone Hcl | 112 | 24 |
| Metoprolol Succinate | Metoprolol Succinate | 111 | 31 |
| Buspirone Hcl | Buspirone Hcl | 106 | 12 |
| Alendronate Sodium | Alendronate Sodium | 105 | 28 |
| Pregabalin | Pregabalin | 102 | 16 |
| Hydrochlorothiazide | Hydrochlorothiazide | 91 | 27 |
| Trulicity | Dulaglutide | 88 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 86 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 86 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 82 | 28 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 82 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 78 | 27 |
| Mirtazapine | Mirtazapine | 78 | 15 |
| Morphine Sulfate Er | Morphine Sulfate | 77 | suppressed |
| Januvia | Sitagliptin Phosphate | 73 | suppressed |
| Meloxicam | Meloxicam | 73 | 18 |
| Myrbetriq | Mirabegron | 72 | 11 |
| Finasteride | Finasteride | 71 | 15 |
| Spironolactone | Spironolactone | 71 | 11 |
| Lorazepam | Lorazepam | 66 | 17 |
| Prednisone | Prednisone | 64 | 27 |
| Amitriptyline Hcl | Amitriptyline Hcl | 62 | 18 |
| Famotidine | Famotidine | 60 | 18 |
| Jardiance | Empagliflozin | 60 | suppressed |
| Carvedilol | Carvedilol | 59 | 15 |
| Allopurinol | Allopurinol | 58 | 20 |
| Cephalexin | Cephalexin | 54 | 22 |
| Warfarin Sodium | Warfarin Sodium | 54 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 50 | 14 |
| Celecoxib | Celecoxib | 49 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 49 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 49 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 48 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 47 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 46 | 17 |
| Atenolol | Atenolol | 45 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 45 | 11 |
| Chlorthalidone | Chlorthalidone | 44 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 43 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 42 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 40 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 38 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 38 | suppressed |
| Primidone | Primidone | 38 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 37 | suppressed |
| Glipizide | Glipizide | 36 | suppressed |
| Ibuprofen | Ibuprofen | 36 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 35 | suppressed |
| Alprazolam | Alprazolam | 34 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 34 | 13 |
| Levetiracetam | Levetiracetam | 34 | suppressed |
| Ozempic | Semaglutide | 34 | suppressed |
| Buprenorphine | Buprenorphine | 33 | suppressed |
| Memantine Hcl | Memantine Hcl | 33 | suppressed |
| Belbuca | Buprenorphine Hcl | 32 | suppressed |
| Nystatin | Nystatin | 32 | 11 |
| Divalproex Sodium | Divalproex Sodium | 30 | suppressed |
| Bupropion Xl | Bupropion Hcl | 29 | suppressed |
| Methocarbamol | Methocarbamol | 29 | 11 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 28 | suppressed |
| Estradiol | Estradiol | 28 | 11 |
| Naproxen | Naproxen | 28 | suppressed |
| Oxycontin | Oxycodone Hcl | 28 | suppressed |
| Clonazepam | Clonazepam | 27 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 27 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 27 | suppressed |
| Bumetanide | Bumetanide | 26 | suppressed |
| Ezetimibe | Ezetimibe | 26 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Budesonide | Budesonide | 24 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | suppressed |
| Aripiprazole | Aripiprazole | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 23 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 23 | suppressed |
| Baclofen | Baclofen | 22 | suppressed |
| Invokana | Canagliflozin | 22 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 22 | suppressed |
| Novolog Flexpen | Insulin Aspart | 22 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Risperidone | Risperidone | 22 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | 14 |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | suppressed |
| Fluconazole | Fluconazole | 21 | 15 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 20 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 20 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 13 |
| Droplet Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Fentanyl | Fentanyl | 20 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 20 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Latanoprost | Latanoprost | 19 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Belsomra | Suvorexant | 18 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 18 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Ibu | Ibuprofen | 18 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | suppressed |
| Synthroid | Levothyroxine Sodium | 18 | suppressed |
| Victoza 2-Pak | Liraglutide | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Eszopiclone | Eszopiclone | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Olanzapine | Olanzapine | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Armour Thyroid | Thyroid,pork | 16 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 16 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Nystop | Nystatin | 16 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 13 |
| Bethanechol Chloride | Bethanechol Chloride | 15 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 14 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 13 | 13 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Victoza 3-Pak | Liraglutide | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 12 | 12 |
| Temazepam | Temazepam | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Butrans | Buprenorphine | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $129.04 · 6 records | ABBVIE INC. | FANAPT, GVOKE HYPOPEN, QULIPTA, UBRELVY | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error